Status:
COMPLETED
Diabetes Prevention In Estrie
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
Ministere de la Sante et des Services Sociaux
Novonordisk endocrine fellowship program
Conditions:
Overweight
Glucose Intolerance
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study compared the efficacy at one year of an interdisciplinary approach including individual counseling and group seminars versus group seminars alone to induce weight loss in subjects at high r...
Detailed Description
Eligible participants will be randomized into 2 intervention groups (30 per group): 1. Small Meeting groups: a curriculum of 25 meeting-seminars will take place for 45 minutes, each one approaching v...
Eligibility Criteria
Inclusion
- pre diabetic state underlined by a marginal fasting glycemia between 6,1 and 6,9 mmol/L and/or a glucose intolerance with glucose confirmed by an OGTT 2 hours
- overweight or obesity (BMI \> 27 kg/m² ; (Body Mass Index))
- enlightened assent
Exclusion
- Impossibility to be present at the visits
- Physical/motor incapacity (or other) making one unable and/or insecure to walk at a moderate to rapid speed of 6 min and more
- Use of an anti-obesity treatment during the last 3 months
- Bariatric Surgery in the past
- Planned Pregnancy
- Pacemaker
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00991549
Start Date
December 1 2004
End Date
January 1 2008
Last Update
October 8 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche Clinique (CRC), Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada